Norethindrone
Who holds supplier records for Norethindrone? 10 organisations hold a current record for Norethindrone: an active US FDA Type II Drug Master File or a CEP. A further 7 organisations have only historical (inactive) DMF filings. 6 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (4), China (2), Netherlands (1), Germany (1) and 1 other country (1); not recorded for 1.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Norethindrone: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/norethindrone
Reading the evidence
- 10 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 6 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (10)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Norethindrone. Country is the organisation's recorded country, not necessarily the manufacturing site.
- ARESKO LIFE SCIENCES PRIVATE LIMITEDIndiaCEPActive DMF 42227 · latest filing Oct 2025
- ASPEN OSS BVNetherlandsCEP Company GMP cert on recordActive DMF 3849 · latest filing May 1980
- Bayer AGGermanyCEP Company GMP cert on recordActive DMF 2726 · latest filing Aug 1976
- VALDEPHARMFranceCEP Company GMP cert on recordActive DMF 24416 · latest filing Mar 2011
- Dr. Reddy's Laboratories Ltd.India Company GMP cert on recordActive DMF 240 · latest filing Jan 1957
- Hubei Gedian Humanwell Pharmaceutical Co. LtdChina Company GMP cert on recordActive DMF 44644 · latest filing Sept 2026
- Lupin LimitedIndia Company GMP cert on recordActive DMF 22505 · latest filing Feb 2009
- NAARI PTE LTDIndiaActive DMF 35803 · latest filing Mar 2021
- ZHEJIANG XIANJU PHARMACEUTICAL CO LTDCEP
- ZHEJIANG XIANJU JUNYE PHARMACEUTICAL CO., LTD.ChinaCEPValid CEP holder (EDQM); not necessarily the manufacturer
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (6)
Certificates of Suitability on the EDQM register for Norethindrone, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 9 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| ARESKO LIFE SCIENCES PRIVATE LIMITED Ramnagar | IN | CEP 2024-251 - Rev 00 Norethisterone | Jun 2026 | — |
| VALDEPHARM Val de Reuil | FR | CEP 2011-094 - Rev 04 Norethisterone, Micronised | Jul 2025 | Inspected Dec 2024 France |
| BAYER AG Leverkusen | DE | CEP 2023-427 - Rev 00 Norethisterone, 202311 | Jun 2024 | — |
| ASPEN OSS B.V. Oss | NL | R1-CEP 1996-041 - Rev 07 Norethisterone | Nov 2022 | — |
| ZHEJIANG XIANJU PHARMACEUTICAL CO., LTD. Xianju | CN | R0-CEP 2022-141 - Rev 00 Norethisterone, Process II | Jul 2022 | — |
| ZHEJIANG XIANJU JUNYE PHARMACEUTICAL CO., LTD. Xianju | CN | R1-CEP 2010-158 - Rev 00 Norethisterone | Aug 2016 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (7)
Organisations whose Type II DMFs for Norethindrone are no longer active. These show a past filing, not current supply.
Show all 7 historical records
- Zhejiang Xianju Junye Pharmaceutical Co., Ltd.(Yangfu site)China · Inactive DMF 24176 · filed Oct 2010
- ROUSSELL UCLAFInactive DMF 8239 · filed Oct 1989
- Hungary · Inactive DMF 3353 · filed Nov 1978
- MITSUBISHI CHEMICAL CORPInactive DMF 2983 · filed Jul 1977
- SCHERING AGInactive DMF 2046 · filed Feb 1973
- United States · Inactive DMF 2010 · filed Oct 1972
- ROUSSEL CORPInactive DMF 1920 · filed Apr 1972
Other forms of this substance
A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:
Overview
Norethindrone is a synthetic progestin used in various hormonal contraceptives and therapies. It functions primarily by inhibiting ovulation and inducing changes in cervical mucus and the endometrium.
Chemical identity
- IUPAC name
- (8R,9S,10R,13S,14S,17R)-17-ethynyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
- Canonical SMILES
- C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=CC(=O)CC[C@H]34
- InChIKey
- VIKNJXKGJWUCNN-XGXHKTLJSA-N
- Synonyms
- Norethisterone, anovule, aranelle component norethindrone, brevicon component norethindrone, camila, femcon fe component norethindrone, gestest, levonorgestrel impurity u, lo minastrin fe component norethindrone, micronor, minastrin 24 fe component norethindrone, nor-qd
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Progestin
- Chemical structure
- Progesterone Congeners
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Norethindrone?
10 organisations hold an active US FDA Type II Drug Master File or a CEP for Norethindrone: ARESKO LIFE SCIENCES PRIVATE LIMITED (India), ASPEN OSS BV (Netherlands), Bayer AG (Germany), VALDEPHARM (France), Dr. Reddy's Laboratories Ltd. (India), Hubei Gedian Humanwell Pharmaceutical Co. Ltd (China), Lupin Limited (India) and NAARI PTE LTD (India), and 2 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Norethindrone Drug Master Files are active?
ARESKO LIFE SCIENCES PRIVATE LIMITED (DMF 42227), ASPEN OSS BV (DMF 3849), Bayer AG (DMF 2726), VALDEPHARM (DMF 24416), Dr. Reddy's Laboratories Ltd. (DMF 240), Hubei Gedian Humanwell Pharmaceutical Co. Ltd (DMF 44644), Lupin Limited (DMF 22505) and NAARI PTE LTD (DMF 35803). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Norethindrone records mean?
7 organisations have only inactive Type II DMFs for Norethindrone. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Norethindrone have a European Certificate of Suitability?
Yes. 6 organisations hold a valid CEP for Norethindrone on the EDQM register, including ARESKO LIFE SCIENCES PRIVATE LIMITED Ramnagar (IN), VALDEPHARM Val de Reuil (FR), BAYER AG Leverkusen (DE), ASPEN OSS B.V. Oss (NL), ZHEJIANG XIANJU PHARMACEUTICAL CO., LTD. Xianju (CN) and ZHEJIANG XIANJU JUNYE PHARMACEUTICAL CO., LTD. Xianju (CN). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
How do I qualify a Norethindrone supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Norethindrone?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.